Monograph
C09CA03 - Valsartan |
Not porphyrinogenic |
NP |
Rationale
Not metabolised.
Chemical description
Angiotensin II receptor antagonist. Bioavailability 23 %. Eliminated in unchanged form. Less potent inhibitor of CYP 2C9. Used in Swedish porphyria ward.
IPNet drug reports
Uneventful use reported in 15 patients with acute porphyria.
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Other sources | |
| 1. | EPNET checked 14.04.10. RLSK
|
|
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Diovan · Exart · Vagrecor · Valsartan 
Diovane · Valsartan 
Aralter · Diovan · Kalpress · Miten · Presar · Vals · Valsartan · Valsartán 
Alsartir · Pressloval · Rixil · Tareg · Valpression · Valsartan 
Diovan · Valsacor 
Diovan · Valsartan 
Daratekan · Diovan · ValHelen · Valsartan 
Diovan · Valsartan 
AuroValsart · Avasart · Axudan · Bespres · Diovan · Dipper-Mono · Tensart · Valsacor · Valsartan · Valtap · Valzek · Vanatex · Walsartan 
Diovane · Valsartan 
Diovan · Docartan · Primartan · Ramartan · Valpress · Valsartan 
Diovan · Valsarstad · Valsartan 
Diovan · Valsacor · Vapress 
Valsacor · Yanida
© NAPOS 2025